182 related articles for article (PubMed ID: 27751836)
1. Hyper-O-GlcNAcylation of YB-1 affects Ser102 phosphorylation and promotes cell proliferation in hepatocellular carcinoma.
Liu Q; Tao T; Liu F; Ni R; Lu C; Shen A
Exp Cell Res; 2016 Dec; 349(2):230-238. PubMed ID: 27751836
[TBL] [Abstract][Full Text] [Related]
2. O-GlcNAcylation promotes the migratory ability of hepatocellular carcinoma cells via regulating FOXA2 stability and transcriptional activity.
Huang H; Wu Q; Guo X; Huang T; Xie X; Wang L; Liu Y; Shi L; Li W; Zhang J; Liu Y
J Cell Physiol; 2021 Nov; 236(11):7491-7503. PubMed ID: 33843053
[TBL] [Abstract][Full Text] [Related]
3. Modification of p27 with O-linked N-acetylglucosamine regulates cell proliferation in hepatocellular carcinoma.
Qiu H; Liu F; Tao T; Zhang D; Liu X; Zhu G; Xu Z; Ni R; Shen A
Mol Carcinog; 2017 Jan; 56(1):258-271. PubMed ID: 27175940
[TBL] [Abstract][Full Text] [Related]
4. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation.
Zhu Q; Zhou L; Yang Z; Lai M; Xie H; Wu L; Xing C; Zhang F; Zheng S
Med Oncol; 2012 Jun; 29(2):985-93. PubMed ID: 21461968
[TBL] [Abstract][Full Text] [Related]
6. O-GlcNAcylation of histone deacetylases 1 in hepatocellular carcinoma promotes cancer progression.
Zhu G; Tao T; Zhang D; Liu X; Qiu H; Han L; Xu Z; Xiao Y; Cheng C; Shen A
Glycobiology; 2016 Aug; 26(8):820-833. PubMed ID: 27060025
[TBL] [Abstract][Full Text] [Related]
7. Y-Box Binding Protein-1 Promotes Epithelial-Mesenchymal Transition in Sorafenib-Resistant Hepatocellular Carcinoma Cells.
Liao LZ; Chen CT; Li NC; Lin LC; Huang BS; Chang YH; Chow LP
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379356
[TBL] [Abstract][Full Text] [Related]
8. Y-box binding protein-1 promotes hepatocellular carcinoma-initiating cell progression and tumorigenesis via Wnt/β-catenin pathway.
Chao HM; Huang HX; Chang PH; Tseng KC; Miyajima A; Chern E
Oncotarget; 2017 Jan; 8(2):2604-2616. PubMed ID: 27911878
[TBL] [Abstract][Full Text] [Related]
9. O-GlcNAcylation on Rab3A attenuates its effects on mitochondrial oxidative phosphorylation and metastasis in hepatocellular carcinoma.
Wu W; Zheng X; Wang J; Yang T; Dai W; Song S; Fang L; Wang Y; Gu J
Cell Death Dis; 2018 Sep; 9(10):970. PubMed ID: 30237463
[TBL] [Abstract][Full Text] [Related]
10. High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate.
Zhou P; Chang WY; Gong DA; Xia J; Chen W; Huang LY; Liu R; Liu Y; Chen C; Wang K; Tang N; Huang AL
Cell Metab; 2023 Nov; 35(11):1961-1975.e6. PubMed ID: 37797623
[TBL] [Abstract][Full Text] [Related]
11. The positive feedback between ACSL4 expression and O-GlcNAcylation contributes to the growth and survival of hepatocellular carcinoma.
Wang J; Wang Z; Yuan J; Wang J; Shen X
Aging (Albany NY); 2020 May; 12(9):7786-7800. PubMed ID: 32357142
[TBL] [Abstract][Full Text] [Related]
12. O-GlcNAcylation of RACK1 promotes hepatocellular carcinogenesis.
Duan F; Wu H; Jia D; Wu W; Ren S; Wang L; Song S; Guo X; Liu F; Ruan Y; Gu J
J Hepatol; 2018 Jun; 68(6):1191-1202. PubMed ID: 29454068
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal-regulated kinase and YB-1 to enhance hepatocarcinogenesis.
Li D; Liu X; Zhou J; Hu J; Zhang D; Liu J; Qiao Y; Zhan Q
Hepatology; 2017 May; 65(5):1612-1627. PubMed ID: 28027578
[TBL] [Abstract][Full Text] [Related]
14. O-GlcNAc modification affects the ATM-mediated DNA damage response.
Miura Y; Sakurai Y; Endo T
Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
[TBL] [Abstract][Full Text] [Related]
15. Translocation of HSP27 into liver cancer cell nucleus may be associated with phosphorylation and O-GlcNAc glycosylation.
Guo K; Gan L; Zhang S; Cui FJ; Cun W; Li Y; Kang NX; Gao MD; Liu KY
Oncol Rep; 2012 Aug; 28(2):494-500. PubMed ID: 22664592
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E.
Cao B; Duan M; Xing Y; Liu C; Yang F; Li Y; Yang T; Wei Y; Gao Q; Jiang J
J Cell Mol Med; 2019 Apr; 23(4):2384-2398. PubMed ID: 30677218
[TBL] [Abstract][Full Text] [Related]
17. Modification of histones by sugar β-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycle-regulated.
Zhang S; Roche K; Nasheuer HP; Lowndes NF
J Biol Chem; 2011 Oct; 286(43):37483-95. PubMed ID: 21896475
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAc modified-TIP60/KAT5 is required for PCK1 deficiency-induced HCC metastasis.
Liu R; Gou D; Xiang J; Pan X; Gao Q; Zhou P; Liu Y; Hu J; Wang K; Tang N
Oncogene; 2021 Dec; 40(50):6707-6719. PubMed ID: 34650217
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of OGT by Caveolin-1 promotes hepatocellular carcinoma cell migration and invasion.
Wang L; Feng Y; Zhang C; Chen X; Huang H; Li W; Zhang J; Liu Y
Cell Biol Int; 2021 Nov; 45(11):2251-2263. PubMed ID: 34288245
[TBL] [Abstract][Full Text] [Related]
20. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
Zhang N; Chen X
Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
